Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Worldwide Offices
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

A Nation Under Pressure: New Hilo Report Reveals Stark Gaps in UK Blood Pressure Awareness, Behaviour and Monitoring

This image opens in the lightbox

News provided by

Aktiia

05 Dec, 2025, 09:00 GMT

Share this article

Share toX

Share this article

Share toX

New evidence shows millions at risk as hypertension awareness falls short across income, age and education groups

LONDON, Dec. 5, 2025 /PRNewswire/ -- Today, Hilo - the medical-grade continuous blood pressure intelligence platform from Aktiia - publishes its inaugural UK Blood Pressure Report: A Nation Under Pressure, featuring a comprehensive dual-dataset analysis of UK blood pressure awareness and roadmap of the educational divide.

Continue Reading
This image opens in the lightbox
Demonstrating everyday blood pressure monitoring with Hilo, the continuous, medical-grade platform featured in Aktiia’s new UK Blood Pressure Report.

Drawing on nationally representative polling of 2,000 UK adults and proprietary, anonymised data from nearly 9,000 long-term Hilo users, the report exposes a nation facing a silent cardiovascular emergency – one fuelled by low awareness, delayed action and major socioeconomic disparities.

By combining public attitudes with long-term physiological data, the report highlights not just what people know, but how they behave in real life. This dual view reveals where awareness breaks down, where assumptions don't match medical reality, and where simple changes could significantly improve national heart health and dramatically reduce public healthcare costs.

Key findings include:

  • Only 47% of the UK public have heard the term 'hypertension' and understand what it means – despite the condition driving more than half of all strokes and heart attacks worldwide.
  • A significant diagnosis gap persists: while just 25% of UK adults report having been diagnosed, government data shows up to one-third are affected - a nearly 10-percentage-point shortfall in diagnosis across the population.
  • Almost 40% of young adults (16–24) believe hypertension has obvious symptoms – despite it typically being symptomless.
  • Awareness of hypertension's links to conditions such as kidney disease, diabetes and vascular dementia is markedly low.
  • Lower-income and lower-education groups consistently show reduced awareness, reduced monitoring and reduced lifestyle engagement, placing them at greater long-term risk.
  • More than 70% of the population had not measured their blood pressure in the past month, with younger adults being the least likely to check.
  • Hilo's long-term data reveals a striking pattern: the age-related climb in systolic blood pressure typically found in adults over 50 appears to be halted among individuals who monitor their blood pressure continuously. This represents real-world evidence that sustained engagement and awareness can support meaningful behavioural change.

Taken together, these insights point to clear opportunities for improvement in how the UK measures, manages, and talks about blood pressure. As government and healthcare bodies continue to focus on prevention and early intervention, this report adds important evidence on where the gaps are – and where targeted communication and easier access to monitoring could make the biggest impact.

Dr Zoe Williams, GP and Resident Doctor on ITV's This Morning, said: 

"Hypertension isn't something to be scared of, it's something to be aware of. When people know their numbers, they are enabled to make healthier choices. What stands out in this report is how knowledge and monitoring really can shift behaviour. If we can improve awareness in all communities and help people take those small, everyday steps earlier, we can prevent a huge amount of heart disease before it ever starts."

Stefan Petzinger, Chief Executive Officer of Aktiia, said:

"We commissioned this study because blood pressure is our core domain, and we needed a clear, fact-based picture of how the UK understands and manages it. What we discovered was eye-opening. Awareness is low, behaviour change is rare, and millions of people are living with risks they don't fully understand.

A third of UK adults have high blood pressure. It is one of the leading causes of heart attacks and strokes – conditions that devastate families yet are often preventable through early detection and consistent management. The gap between risk and action is profound.

This report is a call for urgency. High blood pressure isn't complicated, it's just not talked about enough. That needs to change, and this report is our contribution to putting the issue firmly on the national agenda."

Josep Solà, Chief Technical Officer and Co-Founder of Aktiia, said:

"By pairing public polling with long-term user data from the Hilo platform, we have been able to create a detailed picture of the UK's blood pressure awareness landscape. What stands out is the consistency: low awareness translates into delayed action, and delayed action increases long-term risk.

Our internal data shows that continuous exposure to one's own blood pressure patterns can have a powerful effect. Users over 50 were able to halt, and in some cases reverse, the age-related rise in systolic blood pressure seen in the general population. That kind of behavioural and physiological change has significant potential for public health.

Education, awareness and accessible monitoring are key. The science makes that clear – and the public polling confirms it."

As a proud Prevention Partner of the British & Irish Hypertension Society (BIHS), Hilo is committed to continuing to contribute data and insight to support the national effort towards mitigating the impact of hypertension, and to help more people take control of their blood pressure earlier.

Notes to Editors

About Aktiia:

Founded in 2018 and headquartered in Neuchâtel, Switzerland, Aktiia is the global leader in continuous, cuffless blood pressure monitoring. The company combines advanced optical sensing technology with proprietary algorithms and data-driven insights to empower individuals and clinicians to better monitor and manage hypertension – the world's leading silent killer. Aktiia's technology is clinically validated, FDA-cleared and CE-marked (Class IIa) as a medical device. Its flagship product, the Hilo Band, provides continuous, effortless and accurate blood pressure monitoring through a sleek wrist-worn wearable, integrated with the Hilo companion app. Operating in 12 markets worldwide, Aktiia's mission is to help manage the world's blood pressure through innovation, accessibility and scientific rigor.

For more information about Hilo please visit: https://hilo.com/uk/ 

Photo - https://mma.prnewswire.com/media/2838578/Aktiia.jpg
Logo - https://mma.prnewswire.com/media/2678060/5656211/Hilo_Logo.jpg

Modal title

Also from this source

Aktiia's Hilo Band Becomes First Cuffless Blood Pressure Monitor Cleared by FDA for Over-the-Counter Use

Aktiia's Hilo Band Becomes First Cuffless Blood Pressure Monitor Cleared by FDA for Over-the-Counter Use

Aktiia, a pioneer in optical blood pressure monitoring, announced today that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance ...

Aktiia secures $42 million in Series B funding round and rebrands to Hilo

Aktiia secures $42 million in Series B funding round and rebrands to Hilo

Aktiia, a blood pressure intelligence platform, announces an oversubscribed $42 million (over CHF 34 million) Series B funding round, co-led by...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

Medical Equipment

Medical Equipment

Computer & Electronics

Computer & Electronics

News Releases in Similar Topics

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • PR Newswire Amplify™
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.